Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C09CA07	MICARDIS	B	Telmisartan - 80mg	80mg	Tablet	998,475 L.L
C09DA07	MICARDIS PLUS	B	Telmisartan - 80mg, Hydrochlorothiazide - 12.5mg		Tablet	1,101,951 L.L
D01AC02	MICONAZ	G	Miconazole nitrate - 20mg/g	20mg/g	Gel	427,470 L.L
D01AE14	MYCOSTER	B	Ciclopirox - 8g/100g	8%	Film forming solution	756,583 L.L
D01AE14	MYCOSTER	B	Ciclopirox - 8g/100g	8%	Film forming solution	756,583 L.L
D01AE14	MYCOSTER	B	Ciclopirox - 1%	1%	Cream	284,895 L.L
D02AF	METHYL SALICYLATE COMPOUND UNGUENTUM	G	Methylsalicylate - 4.5g/30g, Menthol - 1.8g/30g		Ointment	165,101 L.L
D03AX	MEBO	B	?-sitosterol - 0.25%	0.25%	Ointment	760,615 L.L
D06AA04	MEPHICYCLINE DERMIQUE	G	Tetracycline HCl - 3%	3%	Ointment	145,903 L.L
D07AC13	METASONE	G	Mometasone furoate - 0.1%	0.1%	Cream	335,321 L.L
D07AC13	METASONE	G	Mometasone furoate - 0.1%	0.1%	Lotion	239,332 L.L
D07CA01	MYCICORT	G	Neomycin sulfate - 5mg/g, Hydrocortisone acetate - 10mg/g		Ointment	485,063 L.L
D10AD51	MEDCLINIDERM-T	G	Tretinoin - 0.025%, Clindamycin (phosphate) - 1%		Gel	801,186 L.L
D10AD51	MEDCLINIDERM-T	G	Tretinoin - 0.05%, Clindamycin (phosphate) - 1%		Gel	890,776 L.L
D10AF01	MEDACIN T	G	Clindamycin (phosphate) - 10mg/ml	10mg/ml	Solution	314,459 L.L
D10AF02	MED-ERYTHROMYCIN 4%	G	Erythromycin - 40mg/ml	4%	Solution	235,492 L.L
D11AX01	MINOXIDIL BAILLEUL	G	Minoxidil - 2%	2%	Solution	2,839,539 L.L
D11AX01	MINOXIDIL BAILLEUL	G	Minoxidil - 5%	5%	Solution	3,675,409 L.L
G01AF02	MICOTER GYNO OVULE	G	Clotrimazole - 500mg	500mg	Pessary	447,948 L.L
G01AF04	MYCODERM-V	G	Miconazole nitrate - 2%	2%	Cream	361,494 L.L
G01AF20	MICOGYL	G	Metronidazole - 500mg, Miconazole nitrate - 100mg		Suppository	362,198 L.L
G02BA03	MIRENA 20mcg/24h Levonorgestrel	B	Levonorgestrel - 20mcg/24h	20mcg/24h	Implant	10,530,753 L.L
G03AA09	MARVELON	B	Ethinylestradiol - 0.03mg, Desogestrel - 0.15mg		Tablet	319,835 L.L
G03AB03	MICROGYNON '30'	B	Ethinylestradiol - 0.03mg, Levonorgestrel - 0.15mg		Tablet, sugar coated	145,135 L.L
G03CA03	MONTADIOL	G	Estradiol - 0.01%	0.01%	Cream	1,105,982 L.L
G03GA02	MENO-CLAIR HP-HMG	BioHuman	Human Menopausal Gonadotrophin, Highly purified - 75IU	75IU	Injectable powder for solution + solution	1,045,509 L.L
G03GA02	MENOPUR	BioHuman	Menotropin - 75IU	75IU	Injectable concentrated powder for solution+diluent	16,864,077 L.L
G03GA02	MERIONAL HG	BioHuman	Menotropin - 75IU	75IU	Injectable powder + solvent	24,771,315 L.L
G03GA02	MENOPUR	BioHuman	Menotropin - 1,200IU	1,200IU	Injectable powder for solution+diluent	27,815,659 L.L
G03GA02	MENOPUR	BioHuman	Menotropin - 600IU	600IU	Injectable powder for solution+diluent	13,907,829 L.L